Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine
This study has been completed.
Study NCT00662870 Information provided by Sanofi-Aventis
First Received: April 17, 2008 Last Updated: August 18, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diphtheria
Tetanus
Whooping Cough
Polio
Haemophilus Influenzae Type B
Additional conditions recognized in this trial
Influenza, Human
Poliomyelitis
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Bordetella Infections
Central Nervous System Diseases
Central Nervous System Infections
Central Nervous System Viral Diseases
Clostridium Infections
Corynebacterium Infections
Enterovirus Infections
Gram-Negative Bacterial Infections
Gram-Positive Bacterial Infections
Infection
Motor Neuron Disease
Myelitis
Nervous System Diseases
Neuromuscular Diseases
Orthomyxoviridae Infections
Picornaviridae Infections
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Spinal Cord Diseases
Virus Diseases
Interventions listed in this trial
DTaP-IPV/Hib
Sponsors listed in this trial
Sanofi-Aventis
Back to top of Main Content
